Logo
Search
Home
Archive
About Author
Subscribe

Archive

Looking at markets through hidden mechanics, not headlines.
When Dividends Move Prices: The Mechanical Trade Around Ex-Date

Apr 3, 2026

•

8 min read

When Dividends Move Prices: The Mechanical Trade Around Ex-Date

Tax rules, futures pricing, and stock-lending frictions.

Andrew Prochnow
Andrew Prochnow
Dell’s Growth is Accelerating, But the Valuation Hasn’t Fully Caught Up

Apr 2, 2026

•

7 min read

Dell’s Growth is Accelerating, But the Valuation Hasn’t Fully Caught Up

AI growth story is accelerating and the valuation still looks modest.

Andrew Prochnow
Andrew Prochnow
Why Municipal Bonds Gap in Silence

Mar 31, 2026

•

7 min read

Why Municipal Bonds Gap in Silence

Fragmented trading, dealer balance sheets, and the price of immediacy.

Andrew Prochnow
Andrew Prochnow
The Stock Drop After “Good” Earnings

Mar 28, 2026

•

8 min read

The Stock Drop After “Good” Earnings

How options, borrow, and dealer inventory turn a report into forced selling.

Andrew Prochnow
Andrew Prochnow
The Calm Valuation That Breaks Later: Private Credit’s Pricing Lag

Mar 27, 2026

•

8 min read

The Calm Valuation That Breaks Later: Private Credit’s Pricing Lag

Appraisals, stale marks, and the sudden need for cash.

Andrew Prochnow
Andrew Prochnow
Why Flexsteel Is Outperforming in a Turbulent Furniture Cycle

Mar 26, 2026

•

7 min read

Why Flexsteel Is Outperforming in a Turbulent Furniture Cycle

The recent selloff has made Flexsteel’s valuation harder to pass up.

Andrew Prochnow
Andrew Prochnow
Why Auction Days Feel “Random”

Mar 24, 2026

•

8 min read

Why Auction Days Feel “Random”

When-issued trading, settlement timing, and balance-sheet capacity.

Andrew Prochnow
Andrew Prochnow
The Selloff With No News

Mar 21, 2026

•

8 min read

The Selloff With No News

Risk budgets that shrink exactly when prices get noisy.

Andrew Prochnow
Andrew Prochnow
Bristol-Myers Squibb: A Pharma Turnaround With Strengthening Fundamentals

Mar 20, 2026

•

7 min read

Bristol-Myers Squibb: A Pharma Turnaround With Strengthening Fundamentals

A compelling turnaround already in motion.

Andrew Prochnow
Andrew Prochnow
Load more

Looking at markets through hidden mechanics, not headlines.